Nicholas Galakatos's Net Worth
Nicholas Galakatos's net worth is estimated to be at least $12,693,574.77 as of 11/08/2024. CoreStreet's estimation of Nicholas Galakatos's net worth is based on their sale of stock and current holding of stock.
Nicholas Galakatos is Director at Entasis Therapeutics Holdings Inc. They have executed at least 3 trades of stock as per SEC Form 4 filings. Their most recent trade was for 453,395 units of ETTX stock on 09/28/2018. Their biggest sale was on 09/17/2018 when they sold 85,823 units of NanoString Technologies Inc stock for $1,372,309.77. They typically trade 1 times per year.
Total value of insider buys:
- $11,321,265.00
Total value of insider sells:
- $1,372,309.77
Most recent insider trade:
- Sept. 28, 2018
Nicholas Galakatos's Insider Trading History
| Entasis Therapeutics Holdings Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 28, 2018 | Director | 453,395 | $15.00 | Buy | $6,800,925.00 |
| NanoString Technologies Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 17, 2018 | Director | 85,823 | $15.99 | Sell | $1,372,309.77 |
| Astria Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 30, 2015 | Director | 376,695 | $12.00 | Buy | $4,520,340.00 |